AU3036597A - Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells - Google Patents
Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cellsInfo
- Publication number
- AU3036597A AU3036597A AU30365/97A AU3036597A AU3036597A AU 3036597 A AU3036597 A AU 3036597A AU 30365/97 A AU30365/97 A AU 30365/97A AU 3036597 A AU3036597 A AU 3036597A AU 3036597 A AU3036597 A AU 3036597A
- Authority
- AU
- Australia
- Prior art keywords
- cells
- stimulate
- specific
- major histocompatibility
- histocompatibility complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65192596A | 1996-05-21 | 1996-05-21 | |
US08651925 | 1996-05-21 | ||
PCT/FR1997/000892 WO1997044667A2 (en) | 1996-05-21 | 1997-05-21 | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3036597A true AU3036597A (en) | 1997-12-09 |
Family
ID=24614802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU30365/97A Abandoned AU3036597A (en) | 1996-05-21 | 1997-05-21 | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3036597A (en) |
WO (1) | WO1997044667A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458354B1 (en) | 1996-03-28 | 2002-10-01 | The Johns Hopkins University | Molecular complexes which modify immune responses |
CA2250166A1 (en) | 1996-03-28 | 1997-10-02 | The Johns Hopkins University | Soluble divalent and multivalent heterodimeric analogs of proteins |
US6268411B1 (en) | 1997-09-11 | 2001-07-31 | The Johns Hopkins University | Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
KR20010075108A (en) * | 1998-09-14 | 2001-08-09 | 라즈 외스테르가아드 페데르센 | A method of producing a functional immunoglobulin superfamily protein |
IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
US20040209314A1 (en) | 1999-09-06 | 2004-10-21 | Institut National De La Sante Et De La Recherche Medicale France | Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA |
FR2798128B1 (en) * | 1999-09-06 | 2001-11-16 | Inst Nat Sante Rech Med | MEANS OF DETECTION AND PURIFICATION OF T CD8 + LYMPHOCYTE POPULATIONS SPECIFIC TO PEPTIDES PRESENT IN THE HLA CONTEXT |
EP1103265A1 (en) * | 1999-11-15 | 2001-05-30 | Leids Universitair Medisch Centrum | T-cells specific for polymorphic proteins on malignant cells |
ES2747357T3 (en) * | 2001-03-14 | 2020-03-10 | Dako Denmark As | MHC molecule constructs and their uses for diagnosis and therapy |
CA2357906A1 (en) * | 2001-09-28 | 2003-03-28 | Institut Pasteur | Identification of new cd8 epitopes from hiv-1 proteins with therapeutical and vaccinal properties against hiv infections |
US20050084967A1 (en) | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
CA2525519A1 (en) | 2003-05-08 | 2004-12-02 | Xcyte Therapies, Inc. | Generation and isolation of antigen-specific t cells |
WO2008116468A2 (en) | 2007-03-26 | 2008-10-02 | Dako Denmark A/S | Mhc peptide complexes and uses thereof in infectious diseases |
EP2167536A1 (en) | 2007-07-03 | 2010-03-31 | Dako Denmark A/S | Mhc multimers, methods for their generation, labeling and use |
EP2197908A2 (en) | 2007-09-27 | 2010-06-23 | Dako Denmark A/S | Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics |
US10968269B1 (en) | 2008-02-28 | 2021-04-06 | Agilent Technologies, Inc. | MHC multimers in borrelia diagnostics and disease |
US10722562B2 (en) | 2008-07-23 | 2020-07-28 | Immudex Aps | Combinatorial analysis and repair |
GB0817244D0 (en) | 2008-09-20 | 2008-10-29 | Univ Cardiff | Use of a protein kinase inhibitor to detect immune cells, such as T cells |
US10369204B2 (en) | 2008-10-02 | 2019-08-06 | Dako Denmark A/S | Molecular vaccines for infectious disease |
US11992518B2 (en) | 2008-10-02 | 2024-05-28 | Agilent Technologies, Inc. | Molecular vaccines for infectious disease |
AU2009332389A1 (en) * | 2008-12-24 | 2011-07-14 | Oncotherapy Science, Inc. | C1orf59 peptides and vaccines including the same |
CN114746152A (en) * | 2020-08-23 | 2022-07-12 | 应用干细胞有限公司 | HLA-F modified cells and methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6496094A (en) * | 1993-03-31 | 1994-10-24 | Abbott Laboratories | Tumor-associated antigens recognized by t cells and the uses of these antigens |
US5514557A (en) * | 1994-06-06 | 1996-05-07 | Genetic Testing Institute Inc. | Method and kit for detecting antibodies specific for HLA and/or platelet glycoproteins |
CN1171156A (en) * | 1994-06-17 | 1998-01-21 | 路德维格癌症研究所 | Method for producing cytolytic T cell specific for complex of peptide and MHC_molecule |
US5595881A (en) * | 1994-08-09 | 1997-01-21 | Anergen, Inc. | Method for the detection of antigen presenting cells |
US5635363A (en) * | 1995-02-28 | 1997-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for the detection, quantitation and purification of antigen-specific T cells |
GB9509844D0 (en) * | 1995-05-16 | 1995-07-12 | Cancer Res Campaign Tech | Screening for inhibitors of TCR-MHC interactions |
-
1997
- 1997-05-21 AU AU30365/97A patent/AU3036597A/en not_active Abandoned
- 1997-05-21 WO PCT/FR1997/000892 patent/WO1997044667A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997044667A2 (en) | 1997-11-27 |
WO1997044667A3 (en) | 1998-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3036597A (en) | Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells | |
AU4175597A (en) | System and method to provide medical electrical stimulation | |
AU7106096A (en) | Catalyst composition and methods for using and preparing same | |
IL126126A0 (en) | Artificial chromosomes uses thereof and methods for preparing artificial chromosomes | |
AU693388B2 (en) | System and method for compressing digitized signals in implantable and battery powered devices | |
AU2079097A (en) | Method and system for optimized scheduling | |
AU8173298A (en) | Bus interface system and method | |
AU2127697A (en) | Method of preparing polynucleotide-carrier complexes for delivery to cells | |
IL127912A0 (en) | Method of activating dendritic cells | |
AU3303797A (en) | Method and system for protein modeling | |
AU2082299A (en) | Method and device for analogue to digital conversion | |
AU4643497A (en) | Method and system for high-temperature waste treatment | |
AU4736297A (en) | System and method for applying thermal energy to tissue | |
AU4670197A (en) | Genetic algorithm scheduling system and method | |
AU8293698A (en) | Apparatus and method for providing power to circuitry implementing two differentpower sources | |
AU4960797A (en) | Use of nucleic acids bound to carrier macromolecules | |
AU5530198A (en) | Compositions and methods for stimulating pancreatic islet cell regeneration | |
AU3324697A (en) | Charging system and method | |
HUP9802674A3 (en) | Solar cell system and method of establishing the system | |
AU7704498A (en) | Human frp and fragments thereof including methods for using them | |
HK1009031A1 (en) | Charging system and method | |
AU6043396A (en) | Composition and methods for creating syngeneic recombinant v irus-producing cells | |
GB2323745B (en) | System and method relating to telecommunications | |
AU7042896A (en) | Method and system for slurry preparation and distribution | |
AU7437798A (en) | Method for potentiating and stimulating plant natural defence system |